{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:14:41Z","timestamp":1774570481104,"version":"3.50.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374478"],"award-info":[{"award-number":["82374478"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2021GXNSFAA196033"],"award-info":[{"award-number":["2021GXNSFAA196033"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Previous epidemiological studies have identified a correlation between serum protein levels and Psoriatic Arthritis (PsA). However, the precise nature of this relationship remains uncertain. Therefore, our objective was to assess whether circulating levels of 2,923 plasma proteins are associated with the risk of PsA, utilizing the Mendelian randomization (MR) approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Two-sample MR analysis was performed to assess the causal impact of proteins on PsA risk. Exposure data for plasma proteins were sourced from a genome-wide association study (GWAS) conducted within the UK Biobank Pharma Proteomics Project, which encompassed 2,923 unique plasma proteins. The outcome data for PsA were sourced from the FinnGen study, a large-scale genomics initiative, comprising 3,537 cases and 262,844 controls. Additionally, colocalization analysis, Phenome-wide MR analysis, and candidate drug prediction were employed to identify potential causal circulating proteins and novel drug targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We thoroughly assessed the association between 1,837 plasma proteins and PsA risk, identifying seven proteins associated with PsA risk. An inverse association of Interleukin-10 (IL-10) with PsA risk was observed [odds ratio (OR)=0.45, 95% confidence interval (CI), 0.28 to 0.70, <jats:italic>P<\/jats:italic><jats:sub>FDR<\/jats:sub>=0.072]. Additionally, Apolipoprotein F (APOF) has a positive effect on PsA risk (OR=2.08, 95% CI, 1.51 to 2.86, <jats:italic>P<\/jats:italic><jats:sub>FDR<\/jats:sub>=0.005). Subsequently, we found strong evidence indicating that IL-10 and APOF were colocalized with PsA associations (PP.H4 = 0.834 for IL-10 and PP.H4 = 0.900 for APOF). Phenome-wide association analysis suggested that these two proteins may have dual effects on other clinical traits (<jats:italic>P<\/jats:italic><jats:sub>FDR<\/jats:sub>&amp;lt;0.1)<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study identified 7 plasma proteins associated with PsA risk, particularly IL-10 and APOF, which offer new insights into its etiology. Further studies are needed to assess the utility and effectiveness of these candidate proteins.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1417564","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T04:30:28Z","timestamp":1720067428000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study"],"prefix":"10.3389","volume":"15","author":[{"given":"Heran","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leilei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhinan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223636","article-title":"Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study","volume":"82","author":"Huss","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"101131","DOI":"10.1016\/j.cpcardiol.2022.101131","article-title":"Cardiovascular diseases in the patients with psoriatic arthritis","volume":"48","author":"Akhlaq","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu264","article-title":"Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study","volume":"54","author":"Tillett","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: history, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","article-title":"Genetics meets proteomics: perspectives for large population-based studies","volume":"22","author":"Suhre","year":"2021","journal-title":"Nat Rev Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/annrheumdis-2019-215356","article-title":"The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies","volume":"78","author":"McGonagle","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00578-0","article-title":"Use of IL-23 inhibitors for the treatment of plaque psoriasis and psoriatic arthritis: A comprehensive review","volume":"22","author":"Yang","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218186","article-title":"IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors","volume":"80","author":"Nerviani","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02693-w","article-title":"Real-world persistence and treatment patterns in patients with psoriatic arthritis treated with anti-IL17 therapy in Spain: the perfIL-17 study","volume":"40","author":"Joven","year":"2023","journal-title":"Adv Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1053\/j.gastro.2023.01.028","article-title":"Proteome-wide mendelian randomization identifies causal links between blood proteins and acute pancreatitis","volume":"164","author":"Bourgault","year":"2023","journal-title":"Gastroenterology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"104494","DOI":"10.1016\/j.ebiom.2023.104494","article-title":"Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses","volume":"89","author":"Chen","year":"2023","journal-title":"EBioMedicine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13073-023-01229-9","article-title":"Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome","volume":"15","author":"Sun","year":"2023","journal-title":"Genome Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12916-023-02736-7","article-title":"Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study","volume":"21","author":"Liu","year":"2023","journal-title":"BMC Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6522","article-title":"Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome","volume":"34","author":"Greco","year":"2015","journal-title":"Stat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PloS Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1038\/s41467-018-06540-3","article-title":"Phenome-wide association studies across large population cohorts support drug target validation","volume":"9","author":"Diogo","year":"2018","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"104488","DOI":"10.1016\/j.ebiom.2023.104488","article-title":"Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases","volume":"89","author":"Yuan","year":"2023","journal-title":"EBioMedicine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12916-023-02863-1","article-title":"Cross-talks between gut microbiota and tobacco smoking: a two-sample Mendelian randomization study","volume":"21","author":"Fan","year":"2023","journal-title":"BMC Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000688","article-title":"Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism","volume":"31","author":"Liu","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/art.38227","article-title":"Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women","volume":"66","author":"Wu","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12944-020-1200-7","article-title":"Higher bodily adiposity, fat intake, and cholesterol serum levels are associated with higher disease activity in psoriatic arthritis patients: is there a link among fat and skin and joint involvement","volume":"19","author":"Leite","year":"2020","journal-title":"Lipids Health Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2018.74021","article-title":"Serum lipid metabolism in psoriasis and psoriatic arthritis - an update","volume":"15","author":"Pietrzak","year":"2019","journal-title":"Arch Med Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1476-9255-7-54","article-title":"Hypercholesterolemia and microvascular dysfunction: interventional strategies","volume":"7","author":"Stapleton","year":"2010","journal-title":"J Inflammation (Lond)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1159\/000375401","article-title":"Reactive oxygen species in psoriasis and psoriasis arthritis: relevance to human disease","volume":"166","author":"Khmaladze","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00962.2008","article-title":"CD40\/CD40L contributes to hypercholesterolemia-induced microvascular inflammation","volume":"296","author":"Stokes","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2006.8.1141","article-title":"Microvascular responses to hypercholesterolemia: the interactions between innate and adaptive immune responses","volume":"8","author":"Stokes","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez204","article-title":"Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis","volume":"58","author":"Mavropoulos","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2017.04.010","article-title":"IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNgamma-producing T cells","volume":"184","author":"Mavropoulos","year":"2017","journal-title":"Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2015-133419","article-title":"TNF-alpha in a molecularly targeted therapy of psoriasis and psoriatic arthritis","volume":"92","author":"Wcislo-Dziadecka","year":"2016","journal-title":"Postgrad Med J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220459","article-title":"One-third of european patients with axial spondyloarthritis reach pain remission with routine care tumor necrosis factor inhibitor treatment","volume":"50","author":"Ornbjerg","year":"2023","journal-title":"J Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac664","article-title":"Utility of nailfold capillary assessment for predicting psoriatic arthritis based on a prospective observational cohort study","volume":"62","author":"Fukasawa","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3697-3","article-title":"Elderly psoriatic arthritis patients on TNF-alpha blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate","volume":"36","author":"Costa","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"11662","DOI":"10.3390\/ijms241411662","article-title":"Inflammatory cytokines in psoriatic arthritis: understanding pathogenesis and implications for treatment","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316069","article-title":"Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis","volume":"111","author":"Ritchlin","year":"2003","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2022.2049157","article-title":"Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations","volume":"21","author":"Qi","year":"2022","journal-title":"Cell Cycle"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3727\/096504017X14876245096439","article-title":"Polymorphic variations associated with doxorubicin-induced cardiotoxicity in breast cancer patients","volume":"25","author":"Todorova","year":"2017","journal-title":"Oncol Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13024-015-0013-z","article-title":"Synaptic dysfunction and septin protein family members in neurodegenerative diseases","volume":"10","author":"Marttinen","year":"2015","journal-title":"Mol Neurodegener"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.3390\/cells9112482","article-title":"Presynaptic vesicle protein SEPTIN5 regulates the degradation of APP C-terminal fragments and the levels of A\u03b2","volume":"9","author":"Marttinen","year":"2020","journal-title":"Cells"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1038\/s41598-021-81550-8","article-title":"Sept8\/SEPTIN8 involvement in cellular structure and kidney damage is identified by genetic mapping and a novel human tubule hypoxic model","volume":"11","author":"Keele","year":"2021","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1995.1014","article-title":"The mouse gene Ptprf encoding the leukocyte common antigen-related molecule LAR: cloning, characterization, and chromosomal localization","volume":"27","author":"Schaapveld","year":"1995","journal-title":"Genomics"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1139\/o04-120","article-title":"Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases","volume":"82","author":"Chagnon","year":"2004","journal-title":"Biochem Cell Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1417564\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T04:30:31Z","timestamp":1720067431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1417564\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2024.1417564"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1417564","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"article-number":"1417564"}}